Lv11
40 积分 2025-02-17 加入
The next generation of antibody–drug conjugates
1小时前
已完结
A novel scaling approach for human pharmacokinetic prediction of antibody-drug conjugates using minimal nonclinical data: Integration of monkey PK and in vitro data
14天前
已完结
Design, simulate, refine: simulation-guided clinical trials for accelerated drug development
17天前
已完结
mRNA 3′UTRs chaperone intrinsically disordered regions to control protein activity
1个月前
已完结
PKBOIN‐12: A Bayesian Optimal Interval Phase I/II Design Incorporating Pharmacokinetics Outcomes to Find the Optimal Biological Dose
1个月前
已完结
Application of Pharmacometrics in Advancing the Clinical Research of Antibody-Drug Conjugates: Principles and Modeling Strategies
2个月前
已完结
Application of Pharmacometrics in Advancing the Clinical Research of Antibody-Drug Conjugates: Principles and Modeling Strategies
2个月前
已完结
Machine Learning for Predicting the Drug-to-Antibody Ratio (DAR) in the Synthesis of Antibody–Drug Conjugates (ADCs)
2个月前
已完结
Towards a translational physiologically-based pharmacokinetic (PBPK) model for receptor-mediated transcytosis of anti-transferrin receptor monoclonal antibodies in the central nervous system
2个月前
已完结
Pharmacology and pharmacokinetics of antibody-drug conjugates, where do we stand?
3个月前
已完结
皖公网安备34019202002308
